Interim18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation – where do we stand?-Reference-Cited by-同舟云学术

Interim18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation – where do we stand?

Published:2009-10-28 Issue:11 Volume:50 Page:1753-1756
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Meignan Michel,Itti Emmanuel,Gallamini Andrea,Haioun Corinne

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190903308056

Reference18 articles.

1. Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma

2. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

3. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT;Skeletal Radiology;2021-08-07

2. Interim FDG-PET Imaging in Lymphoma;Seminars in Nuclear Medicine;2018-01

3. Comparison Between Different PET and CT-Based Imaging Interpretation Criteria at Interim Imaging in Patients With Diffuse Large B-Cell Lymphoma;Clinical Nuclear Medicine;2018-01

4. Contrast-enhanced ultrasound in the therapeutic assessment of diffuse large B-cell lymphoma: A case report;Oncology Letters;2017-08-16

5. Repeatability of SUV in Oncologic 18F-FDG PET;Journal of Nuclear Medicine;2017-02-23